These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28826507)

  • 21. Corrigendum to "A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives" [Bioorg. Med. Chem. Lett. 28 (14) (2018) 2481-2484].
    Derabli C; Boualia I; Abdelwahab AB; Boulcina R; Bensouici C; Kirsch G; Debache A
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3129. PubMed ID: 30119958
    [No Abstract]   [Full Text] [Related]  

  • 22. Retraction notice to "Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats" [Bioorg. Med. Chem. 17 (2007) 15 (2007) 4903-4909].
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L
    Bioorg Med Chem; 2009 Jan; 17(2):930. PubMed ID: 19177601
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis, partition coefficients and antibacterial activity of 3'-phenyl (substituted)-6'-aryl-2' (1H)-cis-3',3'a-dihydrospiro [3-H-indole-3,5'-pyrazolo (3',4'-d)-thiazolo-2-(1H)-ones].
    Sahu SK; Banerjee M; Mishra SK; Mohanta RK; Panda PK; Misro PK
    Acta Pol Pharm; 2007; 64(2):121-6. PubMed ID: 17665861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and benzodiazepine receptor activity of some 4,5-dihydro-1H-pyrazolo[4,3-c][1,8]naphthyridine derivatives.
    Da Settimo A; Primofiore G; Da Settimo F; Simorini F; Barili PL; Senatore G; Martini C; Lucacchini A
    Drug Des Discov; 1994 Jun; 11(4):307-28. PubMed ID: 7727682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924].
    Monteillier A; Loucif A; Omoto K; Stevens EB; Lainez S; Saintot PP; Cao L; Pryde DC
    Bioorg Med Chem Lett; 2017 May; 27(9):2082. PubMed ID: 28320618
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel 3-substituted-1-aryl-5-phenyl-6-anilinopyrazolo[3,4-d]pyrimidin-4-ones: docking, synthesis and pharmacological evaluation as a potential anti-inflammatory agents.
    Yewale SB; Ganorkar SB; Baheti KG; Shelke RU
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6616-20. PubMed ID: 23036953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regioselectively Controlled Synthesis of N-Substituted (Trifluoromethyl)pyrimidin-2(1H)-ones.
    da Silva AM; da Silva FM; Bonacorso HG; Frizzo CP; Martins MA; Zanatta N
    J Org Chem; 2016 May; 81(9):3727-34. PubMed ID: 27070191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retraction notice to "Carboxylated calixarenes bind strongly to CD69 and protect CD69(+) killer cells from suicidal cell death induced by tumor cell surface ligands" [Bioorg. Med. Chem. 18 (4) (2010) 1434–1440].
    Bioorg Med Chem; 2014 Jun; 22(12):3227. PubMed ID: 24955474
    [No Abstract]   [Full Text] [Related]  

  • 29. Simple approach to thieno[3,2-d]pyrimidines as new scaffolds of antimicrobial activities.
    Hafez HN; El-Gazzar AR; Zaki ME
    Acta Pharm; 2016 Sep; 66(3):331-51. PubMed ID: 27383884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 4-Substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, antitumor and EGFR tyrosine kinase inhibitory activity.
    Abbas SE; Aly EI; Awadallah FM; Mahmoud WR
    Chem Biol Drug Des; 2015 May; 85(5):608-22. PubMed ID: 25318985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of some novel pyrazolo[3,4-d]pyrimidine derivatives as potential antimicrobial agents.
    Holla BS; Mahalinga M; Karthikeyan MS; Akberali PM; Shetty NS
    Bioorg Med Chem; 2006 Mar; 14(6):2040-7. PubMed ID: 16310361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor Xa.
    Li YL; Fevig JM; Cacciola J; Buriak J; Rossi KA; Jona J; Knabb RM; Luettgen JM; Wong PC; Bai SA; Wexler RR; Lam PY
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5176-82. PubMed ID: 16870435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corrigendum to "Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase" [Bioorg. Med. Chem. Lett. 29 (2019) 1918-1921].
    Kim SH; Johnson JA; Jiang J; Parkhurst B; Phillips M; Pi Z; Qiao JX; Tora G; Ye Chen A; Liu E; Yin X; Yang R; Zhao L; Taylor DS; Basso M; Behnia K; Onorato J; Chen XQ; Abell LM; Lu H; Locke G; Caporuscio C; Adam LP; Gordon D; Wexler RR; Finlay HJ
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2525. PubMed ID: 31353296
    [No Abstract]   [Full Text] [Related]  

  • 34. Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606].
    Li J; Li D; Xu Y; Guo Z; Liu X; Yang H; Wu L; Wang L
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3822. PubMed ID: 30385163
    [No Abstract]   [Full Text] [Related]  

  • 35. Corrigendum to "Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5 [Bioorg Med Chem Lett 28 (17) (2018) 2930-2938]".
    Khathi SP; Chandrasekaran B; Karunanidhi S; Tham CL; Kozielski F; Sayyad N; Karpoormath R
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3489. PubMed ID: 30279037
    [No Abstract]   [Full Text] [Related]  

  • 36. Corrigendum to "Identification of 2-substituted pyrrolo[1,2-b]pyridazine derivatives as new PARP-1 inhibitors" [Bioorg. Med. Chem. Lett. 31 (2021) 127710].
    Xiang HY; Chen JY; Huan XJ; Chen Y; Gao ZB; Ding J; Miao ZH; Yang CH
    Bioorg Med Chem Lett; 2022 Jan; 56():128501. PubMed ID: 34911648
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis and herbicidal activity of novel pyrazolo[3,4-d]pyrimidin-4-one derivatives containing aryloxyphenoxypropionate moieties.
    Liu H; Wang HQ; Liu ZJ
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2203-9. PubMed ID: 17337186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyrimidines. Part II: Synthesis of novel pyrimidines, 1,2,4-triazolo[4,3-a]pyrimidin-7-ones and pyrimidino[2,1-c][1,2,4]triazin-8-ones for their antimicrobial and anticancer activities.
    Habib NS; Soliman R; Ismail K; Hassan AM; Sarg MT
    Boll Chim Farm; 2003 Nov; 142(9):396-405. PubMed ID: 14971308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators.
    Qi J; Zhang F; Mi Y; Fu Y; Xu W; Zhang D; Wu Y; Du X; Jia Q; Wang K; Zhang H
    Eur J Med Chem; 2011 Mar; 46(3):934-43. PubMed ID: 21296466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivo.
    Yang LL; Li GB; Ma S; Zou C; Zhou S; Sun QZ; Cheng C; Chen X; Wang LJ; Feng S; Li LL; Yang SY
    J Med Chem; 2013 Feb; 56(4):1641-55. PubMed ID: 23362959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.